By Torie Wells

Orbiting Earth at this moment, on board the International Space Station (ISS), is a unique experiment that could help scientists and engineers learn more about the mechanics of diseases like Alzheimer’s, Parkinson’s, and type-II diabetes.

This experiment hinges on a novel approach for studying the fluid dynamics associated with these diseases, in a way that more closely mimics many aspects of the human body. It was conceived by Amir Hirsa, a professor of mechanical, aerospace, and nuclear engineering at Rensselaer, and it requires a microgravity environment — making the ISS the best place to test it out.

“People are realizing that fluid dynamics is not a secondary issue; it may be a primary issue physiologically,” Hirsa said. “Understanding the relationship between fluid flow and amyloid formation might be a small but important step in understanding a disease and working toward a cure.”

Amyloid fibrils are clusters of proteins that are linked to neurodegenerative diseases. Fluid motion in the body causes shear stress, which increases the rate at which proteins lose their natural form and turn into fibrils, Hirsa said. Studying this process on Earth is complicated by containers — needed to hold the fluid — interfering with the fibril formation process.

Hirsa’s concept, which he calls a “ring-sheared drop,” will allow protein aggregation to be studied without a container. In a microgravity environment, Hirsa points out, surface tension can hold the fluid together. This will allow researchers to observe how proteins react to stress without having to account for how the solid walls of a dish may also be affecting them.

On July 25, a rocket bound for the ISS launched from Cape Canaveral Air Force Station in Florida. Among other things, it was carrying the ring-sheared drop hardware built by NASA — inspired by Hirsa — and samples of the human recombinant insulin protein prepared by Hirsa’s group to be used in this experiment.

Hirsa and his team are now waiting for the hardware to be installed and their experiment to begin. Once it has, a syringe will dispense a large drop of liquid made up of water and dissolved insulin. The drop will attach to a stationary thin ring on one side and another thin ring on the other side that can rotate. The rotating ring can be spun to shear the protein, significantly accelerating the formation of amyloids.

Prior to the launch, NASA engineers and contractors traveled to Rensselaer for a week to certify the team’s samples for flight. The NASA team also set up a communications network in the basement of the Jonsson Engineering Center at Rensselaer, where Hirsa’s team will continuously monitor the experiment visually as it remains in space for weeks. The researchers will be able to control the level of shear, and operate a microscope and other probes that monitor protein fibril formation.

 

“The fact that we are taking something on Earth that we can’t really study on Earth and going to space in order to rule out some variables is incredibly interesting,” said Nick Debono, an aerospace engineering doctoral student who is part of Hirsa’s research team. “Even more interesting is that it’s never been done before.”

“This is a dream come true,” Hirsa said. “Being able to help with human health research wasn’t in my original training, but thank God I was able to apply fundamental science to something that’s really exciting and affects a large portion of society.”

 Hirsa anticipates this method will be used by other research teams aboard the ISS in the future. If the concept works, he plans to expand his team’s investigation to other proteins like the ones associated with Parkinson’s and Alzheimer’s.

The Rensselaer researchers envision future experiments where they mimic what happens in the body even further by coating the ring-sheared drop with the oily films that form our cell membranes. Their work could even enable future development of pharmaceuticals on Earth and in space.

“If this experiment is successful, there are different avenues where you can actually use the developed hardware and technology to study, for example, bacterial film formation at interfaces in space,” said Aditya Raghunandan, a mechanical engineering postdoctoral fellow working on this research. “Also, if the pharmaceutical industry develops a new drug to cure Alzheimer’s, or cure Parkinson’s, we can use the ring-sheared drop to understand the stability and efficacy of the new drug in the presence of stress and interfaces.”

“What’s next?” Hirsa said. “That’s a very important question: What’s next?”

This research project is supported by funding from NASA’s George C. Marshall Space Flight Center.